AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgi
Pivotal Milestone Accelerates Pathway to Specific IndicationLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of lif...
Source: pharmiweb.com